Understanding Uveitis in Children Under 18
Part of Eyes & vision clinical trials.
This study looks at uveitis, a type of eye inflammation, in children. Researchers want to learn more about different types of uveitis and how they affect children, whether the inflammation is new or has been going on for a while.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is under 17 years old if uveitis started recently (within 6 months), or under 18 if it started more than 6 months ago
- Your child has been diagnosed with uveitis (eye inflammation) that is not from an injury or surgery
- Your child's uveitis is not caused by trauma (eye injury) or post-operative complications (problems after eye surgery)
- No immediate family members work at the research center or are involved with this study
- Your child does not have certain other eye conditions like retinoblastoma, Coat's disease, or inherited retinal problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at children with long-term eye inflammation that is not caused by an infection. It aims to learn more about the condition and how to better help patients.
This study follows people who have been diagnosed with uveitis (inflammation inside the eye). It helps researchers better understand the condition and how people do over time.
This study looks at genetic (inherited) differences in people with uveitis. The goal is to better understand what may cause uveitis and potentially help with future treatments.
This trial uses a new genetic test to find the cause of eye inflammation when standard tests haven't. The goal is to see if this approach can identify hidden infections and help doctors choose the right treatment to protect your vision.
This study tests a new drug (GenSci048) for people with active, non-infectious uveitis in the middle or back of the eye, who are already taking oral steroids. The goal is to see if the drug can better control inflammation and reduce the need for steroids.
This trial screens people with certain eye inflammation (uveitis) to see if they might have a specific rare lymphoma linked to immune cells. It may help doctors identify the right diagnosis and understand which patients need closer monitoring.
Hear when a new Uveitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.